7Baggers
 united states neurofibromatosis type 2 market set to surge with  openPR.com Tue, 30 Sep 2025 09:21:30 GMT
 Published on: 2025-09-21 06:43:55  خودرو بانک Sun, 21 Sep 2025 03:17:09 GMT
 portfolio shifts: is ikena oncology inc. a stock for growth or value investors  خودرو بانک Thu, 18 Sep 2025 05:32:22 GMT
 published on: 2025-09-15 05:11:11  newser.com Mon, 15 Sep 2025 10:11:11 GMT
 published on: 2025-09-12 13:59:20  Newser Fri, 12 Sep 2025 18:59:20 GMT
 published on: 2025-09-11 23:02:30  Newser Fri, 12 Sep 2025 04:02:30 GMT
 published on: 2025-09-11 04:45:06  Newser Thu, 11 Sep 2025 09:45:06 GMT
 published on: 2025-09-10 23:43:52  Newser Thu, 11 Sep 2025 04:43:52 GMT
 published on: 2025-09-09 06:11:42  Newser Tue, 09 Sep 2025 11:11:42 GMT
 published on: 2025-09-08 21:21:03  Newser Tue, 09 Sep 2025 02:21:03 GMT

Ikena Oncology, Inc
(NASDAQ:IKNA) 

IKNA stock logo

Ikena Oncology, Inc., a targeted oncology company, focuses on developing novel cancer therapies targeting key signaling pathways that drive the formation and spread of cancer. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced ass...

Founded: 2016
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends